Inventiva Correlations
| IVA Stock | USD 6.17 0.03 0.48% |
The current 90-days correlation between Inventiva Sa and Fluoropharma Medical is 0.09 (i.e., Significant diversification). The correlation of Inventiva is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Inventiva Correlation With Market
Poor diversification
The correlation between Inventiva Sa and DJI is 0.73 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Inventiva Sa and DJI in the same portfolio, assuming nothing else is changed.
Inventiva | Build AI portfolio with Inventiva Stock |
Moving together with Inventiva Stock
| 0.79 | GXEA | Galapagos NV Earnings Call This Week | PairCorr |
| 0.92 | 8VP1 | AVRICORE HEALTH INC | PairCorr |
| 0.71 | VALN | Valneva SE ADR | PairCorr |
| 0.63 | DNLI | Denali Therapeutics | PairCorr |
| 0.79 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.88 | 6C1 | CytomX Therapeutics | PairCorr |
| 0.91 | DRTS | Alpha Tau Medical | PairCorr |
| 0.69 | DSGN | Design Therapeutics | PairCorr |
| 0.65 | SAB | Sonic Healthcare Earnings Call This Week | PairCorr |
| 0.9 | 0P6S | Bayer AG NA | PairCorr |
| 0.85 | DVAX | Dynavax Technologies Earnings Call This Week | PairCorr |
Moving against Inventiva Stock
| 0.68 | OSE | OSE Pharma SA | PairCorr |
| 0.55 | RAC | Race Oncology Earnings Call This Week | PairCorr |
| 0.5 | VCYT | Veracyte | PairCorr |
| 0.5 | DRMA | Dermata Therapeutics | PairCorr |
| 0.49 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.4 | VCEL | Vericel Corp Ord | PairCorr |
| 0.34 | ALSEN | Sensorion SA | PairCorr |
| 0.83 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.78 | VRAX | Virax Biolabs Group | PairCorr |
| 0.78 | VSTM | Verastem | PairCorr |
| 0.76 | XE9 | Xencor Inc | PairCorr |
| 0.74 | DTIL | Precision BioSciences | PairCorr |
| 0.74 | VKTX | Viking Therapeutics | PairCorr |
| 0.7 | IGS1 | India Globalization | PairCorr |
| 0.69 | CDTTW | Conduit Pharmaceuticals | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Inventiva Stock performing well and Inventiva Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Inventiva's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| KLDO | 146.28 | 73.72 | 0.00 | (4.50) | 0.00 | 0.00 | 4,998 | |||
| IVBT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| XENO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CALA | 21.70 | 5.87 | 0.08 | (1.50) | 20.34 | 100.00 | 280.00 | |||
| NMRD | 1.49 | (0.80) | 0.00 | (1.46) | 0.00 | 0.00 | 50.00 | |||
| SYVC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SNNAQ | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| FPMI | 2.98 | 1.42 | 0.00 | 1.07 | 0.00 | 0.00 | 100.00 |
Inventiva Corporate Management
| Jean Volatier | Chief Officer | Profile | |
| Nazira MD | Chief Officer | Profile | |
| Frederic Cren | CEO CoFounder | Profile | |
| Michael Cooreman | Chief Officer | Profile | |
| Pierre Broqua | Chief CoFounder | Profile |